Jia Zhiwei, Yang Pushan, Wu Yaohong, Tang Yong, Zhao Yachao, Wu Jianhong, Wang Deli, He Qing, Ruan Dike
Department of Orthopaedics, Navy General Hospital, Beijing 100048, P.R. China.
Department of Orthopaedics, Clinical Center in Beijing Space, The 306th Hospital of People's Liberation Army, Beijing 100094, P.R. China.
Exp Ther Med. 2017 Jun;13(6):3574-3580. doi: 10.3892/etm.2017.4398. Epub 2017 Apr 27.
Cell therapy using mesenchymal stem cells provides a promising approach for the treatment of intervertebral disc degeneration (IDD). In recent years, human nucleus pulposus mesenchymal stem cells (NPMSCs) have been identified in nucleus pulposus tissue and displayed great potential for the regeneration of IDD. However, biological differences between non-degenerative and degenerative nucleus pulposus-derived NPMSCs have remained to be defined. The aim of the present study was to compare the biological characteristics of human NPMSCs derived from non-degenerative and degenerative nucleus pulposus. NPMSCs were isolated from non-degenerative and degenerative nucleus pulposus, which were assessed using the Pfirrmann grading system. The biological characteristics of the NPMSCs, including the expression of surface markers, multipotent differentiation, colony formation, chemotactic cell migration, cell activity and stemness gene expression were compared. It was found that NPMSCs could be obtained from non-degenerative and degenerative human nucleus pulposus. However, degenerative nucleus pulposus-derived NPMSCs displayed decreased ability of colony formation, chemotactic migration, cell activity and expression of stemness genes compared with non-degenerative nucleus pulposus-derived NPMSCs. Therefore, NPMSCs derived from non-degenerative and degenerative nucleus pulposus show different biological behaviors. The degenerative status of nucleus pulposus tissue should be considered when selecting NPMSCs as a source for clinical application.
使用间充质干细胞的细胞疗法为椎间盘退变(IDD)的治疗提供了一种有前景的方法。近年来,人髓核间充质干细胞(NPMSCs)已在髓核组织中被鉴定出来,并在IDD再生方面显示出巨大潜力。然而,非退变和退变髓核来源的NPMSCs之间的生物学差异仍有待明确。本研究的目的是比较源自非退变和退变髓核的人NPMSCs的生物学特性。从非退变和退变髓核中分离出NPMSCs,并用Pfirrmann分级系统进行评估。比较了NPMSCs的生物学特性,包括表面标志物的表达、多能分化、集落形成、趋化细胞迁移、细胞活性和干性基因表达。结果发现,NPMSCs可以从非退变和退变的人髓核中获得。然而,与非退变髓核来源的NPMSCs相比,退变髓核来源的NPMSCs的集落形成能力、趋化迁移能力、细胞活性和干性基因表达均降低。因此,源自非退变和退变髓核的NPMSCs表现出不同的生物学行为。在选择NPMSCs作为临床应用来源时,应考虑髓核组织的退变状态。